STOK Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 11.30%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $70,072,128.56

Stoke Therapeutics Insider Trading History Chart

Stoke Therapeutics Share Price & Price History

^$7.21

▼ -0.24 (-3.22%)

As of 03/28/2025 05:00 PM ET

Days: 30 | 90 | 365

Stoke Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/18/2025	Barry Ticho	Insider	Sell	3,884	$8.67	$33,674.28	63,962
3/18/2025	Edward M Md Kaye	Director	Sell	10,382	$8.67	$90,011.94	148,253
3/18/2025	Jonathan Allan	General Counsel	Sell	2,266	$8.67	$19,646.22	33,510
12/9/2024	Barry Ticho	Insider	Sell	2,586	$12.99	$33,592.14	44,746
12/9/2024	Edward M Md Kaye	CEO	Sell	6,786	$12.99	$88,150.14	61,885
12/9/2024	Jonathan Allan	General Counsel	Sell	13,666	$13.61	$185,994.26	21,476
12/6/2024	Barry Ticho	Insider	Sell	13,945	$12.78	$178,217.10	47,332
12/6/2024	Edward M Md Kaye	CEO	Sell	6,170	$12.78	$78,852.60	68,671
12/6/2024	Jonathan Allan	General Counsel	Sell	9,696	$12.78	$123,914.88	35,142
12/2/2024	Barry Ticho	Insider	Sell	10,000	$12.07	$120,700.00	51,277
9/19/2024	Skorpios Trust	Major Shareholder	Sell	1,937,500	$14.05	$27,221,875.00	8,906,181
7/1/2024	Barry Ticho	Insider	Sell	10,000	$13.75	$137,500.00	2,485
4/17/2024	Skorpios Trust	Major Shareholder	Sell	3,600,000	$11.60	$41,760,000.00	10,843,681
3/28/2024	Jonathan Allan	General Counsel	Sell	5,126	$13.20	$67,663.20	2,598
3/19/2024	Edward M Md Kaye	CEO	Sell	11,150	$6.10	$68,015.00	69,350
3/19/2024	Jonathan Allan	General Counsel	Sell	2,349	$6.10	$14,328.90	7,724
3/19/2024	Stephen J Tulipano	CFO	Sell	4,116	$6.10	$25,107.60	20,746
2/1/2024	Barry Ticho	Insider	Sell	10,000	$4.80	$48,000.00	6,981
1/2/2024	Barry Ticho	Insider	Sell	10,000	$5.74	$57,400.00	16,981
7/3/2023	Barry Ticho	Insider	Sell	15,000	$10.60	$159,000.00	25,895
6/21/2023	Jonathan Allan	General Counsel	Sell	1,948	$13.48	$26,259.04
6/1/2023	Barry Ticho	Insider	Sell	15,000	$11.13	$166,950.00	40,895
5/3/2023	Barry Ticho	Insider	Sell	24,697	$10.14	$250,427.58	56,548
5/1/2023	Barry Ticho	Insider	Sell	24,967	$10.00	$249,670.00	86,758
2/6/2023	Barry Ticho	Insider	Sell	9,235	$10.02	$92,534.70	111,725
2/2/2023	Barry Ticho	Insider	Sell	267	$10.00	$2,670.00	124,723
1/31/2023	Barry Ticho	Insider	Sell	200	$10.00	$2,000.00	130,695

See Full Table

SEC Filings (Institutional Ownership Changes) for Stoke Therapeutics (NASDAQ:STOK)

Institutional Buying and Selling by Quarter

Stoke Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/24/2025	Wellington Management Group LLP	134,812	$1.49M	0.0%	-1.6%	0.249%
3/18/2025	California State Teachers Retirement System	32,068	$0.35M	0.0%	+16.2%	0.061%
2/19/2025	Toronto Dominion Bank	3,173,258	$35M	0.1%	N/A	5.991%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	95,505	$1.05M	0.0%	+123.7%	0.180%
2/17/2025	Voloridge Investment Management LLC	86,888	$0.96M	0.0%	-29.4%	0.164%
2/17/2025	Squarepoint Ops LLC	120,242	$1.33M	0.0%	+6.7%	0.227%
2/17/2025	Two Sigma Investments LP	53,950	$0.60M	0.0%	-53.8%	0.102%
2/17/2025	Tang Capital Management LLC	300,000	$3.31M	0.2%	N/A	0.566%
2/17/2025	Toronto Dominion Bank	3,173,258	$35M	0.1%	N/A	5.991%
2/17/2025	RTW Investments LP	5,123,525	$56.51M	0.9%	+10.1%	9.673%
2/17/2025	Rafferty Asset Management LLC	67,227	$0.74M	0.0%	-18.8%	0.127%
2/17/2025	Redmile Group LLC	4,593,629	$50.67M	3.5%	-2.5%	8.672%
2/17/2025	ProShare Advisors LLC	12,626	$0.14M	0.0%	N/A	0.024%
2/17/2025	MPM Bioimpact LLC	685,826	$7.57M	1.1%	+43.0%	1.295%
2/17/2025	Millennium Management LLC	76,829	$0.85M	0.0%	+417.9%	0.145%
2/17/2025	Group One Trading LLC	104,411	$1.15M	0.0%	+2.8%	0.197%
2/17/2025	Graham Capital Management L.P.	18,634	$0.21M	0.0%	+8.5%	0.035%
2/17/2025	Granahan Investment Management LLC	567,689	$6.26M	0.3%	-12.0%	1.072%
2/17/2025	D. E. Shaw & Co. Inc.	28,043	$0.31M	0.0%	-83.6%	0.053%
2/17/2025	Deutsche Bank AG	350,614	$3.87M	0.0%	-24.2%	0.662%
2/17/2025	DAFNA Capital Management LLC	171,097	$1.89M	0.5%	-17.5%	0.323%
2/17/2025	Baker BROS. Advisors LP	4,633,838	$51.11M	0.5%	+6.1%	8.748%
2/17/2025	Bank of America Corp DE	9,091	$100K	0.0%	-92.7%	0.017%
2/17/2025	BNP Paribas Financial Markets	4,422	$49K	0.0%	-94.2%	0.008%
2/17/2025	Ameriprise Financial Inc.	10,527	$0.12M	0.0%	-26.5%	0.020%
2/14/2025	Jane Street Group LLC	11,977	$0.13M	0.0%	-96.4%	0.023%
2/14/2025	Freestone Grove Partners LP	18,049	$0.20M	0.0%	N/A	0.034%
2/14/2025	Schonfeld Strategic Advisors LLC	291,795	$3.22M	0.0%	N/A	0.551%
2/14/2025	Northern Trust Corp	350,788	$3.87M	0.0%	+3.4%	0.662%
2/14/2025	Tudor Investment Corp ET AL	18,258	$0.20M	0.0%	N/A	0.034%
2/14/2025	Gilder Gagnon Howe & Co. LLC	92,546	$1.02M	0.0%	+2.0%	0.175%
2/14/2025	Price T Rowe Associates Inc. MD	37,455	$0.41M	0.0%	+6.3%	0.071%
2/14/2025	Tower Research Capital LLC TRC	11,930	$0.13M	0.0%	+70.1%	0.023%
2/14/2025	Dimensional Fund Advisors LP	538,900	$5.94M	0.0%	+103.4%	1.017%
2/13/2025	CANADA LIFE ASSURANCE Co	9,716	$0.11M	0.0%	-14.4%	0.018%
2/13/2025	Marshall Wace LLP	951,432	$10.49M	0.0%	-43.1%	1.796%
2/13/2025	Renaissance Technologies LLC	129,043	$1.42M	0.0%	N/A	0.244%
2/13/2025	Legal & General Group Plc	35,347	$0.39M	0.0%	-5.7%	0.067%
2/13/2025	Invesco Ltd.	12,065	$0.13M	0.0%	N/A	0.023%
2/13/2025	Wells Fargo & Company MN	16,786	$0.19M	0.0%	+51.2%	0.032%
2/12/2025	Trexquant Investment LP	103,031	$1.14M	0.0%	-36.3%	0.195%
2/12/2025	Geode Capital Management LLC	877,095	$9.68M	0.0%	+0.7%	1.656%
2/12/2025	Wellington Management Group LLP	134,812	$1.49M	0.0%	-1.6%	0.255%
2/12/2025	Norges Bank	314,800	$3.47M	0.0%	N/A	0.594%
2/12/2025	JPMorgan Chase & Co.	19,964	$0.22M	0.0%	+29.2%	0.038%
2/11/2025	EntryPoint Capital LLC	31,968	$0.35M	0.1%	N/A	0.060%
2/11/2025	Corebridge Financial Inc.	17,861	$0.20M	0.0%	-6.1%	0.034%
2/11/2025	Vanguard Group Inc.	2,731,198	$30.13M	0.0%	-1.0%	5.156%
2/11/2025	KLP Kapitalforvaltning AS	5,700	$63K	0.0%	N/A	0.011%
2/11/2025	Teacher Retirement System of Texas	10,219	$0.11M	0.0%	N/A	0.019%
2/10/2025	Swiss National Bank	67,300	$0.74M	0.0%	+20.4%	0.127%
2/6/2025	Charles Schwab Investment Management Inc.	342,129	$3.77M	0.0%	+8.2%	0.646%
2/5/2025	Skorpios Trust	6,906,181	$76.18M	99.8%	-22.5%	13.038%
2/4/2025	Los Angeles Capital Management LLC	43,438	$0.48M	0.0%	-57.8%	0.082%
2/4/2025	Bank of New York Mellon Corp	93,195	$1.03M	0.0%	+1.4%	0.176%
1/30/2025	Rhumbline Advisers	49,374	$0.55M	0.0%	+6.0%	0.093%
1/24/2025	China Universal Asset Management Co. Ltd.	11,231	$0.12M	0.0%	N/A	0.021%
1/17/2025	SG Americas Securities LLC	10,768	$0.12M	0.0%	-27.8%	0.020%
1/14/2025	Assenagon Asset Management S.A.	1,350,925	$14.90M	0.0%	+2.9%	2.551%
12/13/2024	Exome Asset Management LLC	176,600	$2.17M	1.5%	N/A	0.333%
11/27/2024	Franklin Resources Inc.	22,314	$0.29M	0.0%	-98.2%	0.042%
11/19/2024	Barclays PLC	79,740	$0.98M	0.0%	+145.3%	0.151%
11/16/2024	Geode Capital Management LLC	870,831	$10.71M	0.0%	+9.7%	1.644%
11/15/2024	Barclays PLC	79,740	$0.98M	0.0%	+145.3%	0.151%
11/15/2024	Jane Street Group LLC	330,442	$4.06M	0.0%	+338.2%	0.624%
11/15/2024	Wellington Management Group LLP	136,975	$1.68M	0.0%	-4.6%	0.259%
11/15/2024	State Street Corp	1,728,888	$21.25M	0.0%	+8.6%	3.264%
11/15/2024	RTW Investments LP	4,652,285	$57.18M	0.8%	+10.1%	8.783%
11/15/2024	Redmile Group LLC	4,713,509	$57.93M	3.4%	-0.2%	8.898%
11/15/2024	Checkpoint Capital L.P.	157,514	$1.94M	1.0%	N/A	0.297%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	42,692	$0.53M	0.0%	-25.6%	0.081%
11/13/2024	BNP Paribas Financial Markets	76,154	$0.94M	0.0%	+1,589.7%	0.144%
11/13/2024	FMR LLC	322,949	$3.97M	0.0%	-18.9%	0.610%
11/12/2024	Charles Schwab Investment Management Inc.	316,134	$3.89M	0.0%	+9.3%	0.597%
11/9/2024	Intech Investment Management LLC	13,052	$0.16M	0.0%	N/A	0.025%
11/4/2024	Los Angeles Capital Management LLC	103,005	$1.27M	0.0%	+54.3%	0.196%
11/2/2024	Mesirow Financial Investment Management Inc.	15,604	$0.19M	0.0%	N/A	0.030%
10/23/2024	Skorpios Trust	8,906,181	$109.46M	99.8%	-17.9%	16.916%
10/23/2024	Assenagon Asset Management S.A.	1,312,479	$16.13M	0.0%	-10.6%	2.493%
10/3/2024	SG Americas Securities LLC	14,917	$0.18M	0.0%	-78.3%	0.029%
9/20/2024	Healthcare of Ontario Pension Plan Trust Fund	1,387,200	$18.74M	0.1%	+426.1%	2.635%
9/4/2024	Ghisallo Capital Management LLC	15,000	$0.20M	0.0%	-50.0%	0.028%
8/15/2024	Lynx1 Capital Management LP	5,185,191	$70.05M	25.3%	+40.3%	9.848%
8/15/2024	The Manufacturers Life Insurance Company	13,964	$0.19M	0.0%	+16.7%	0.027%
8/15/2024	Millennium Management LLC	289,067	$3.91M	0.0%	+528.6%	0.549%
8/14/2024	Squarepoint Ops LLC	15,042	$0.20M	0.0%	-70.6%	0.029%
8/14/2024	Marshall Wace LLP	1,161,037	$15.69M	0.0%	+550.1%	2.205%
8/14/2024	Logos Global Management LP	1,050,000	$14.19M	1.1%	N/A	1.994%
8/14/2024	Profund Advisors LLC	14,893	$0.20M	0.0%	N/A	0.028%
8/9/2024	Renaissance Technologies LLC	11,200	$0.15M	0.0%	-41.4%	0.021%
8/9/2024	Dimensional Fund Advisors LP	191,360	$2.59M	0.0%	-12.9%	0.367%
8/8/2024	American Century Companies Inc.	59,149	$0.80M	0.0%	+99.4%	0.113%
8/6/2024	Quest Partners LLC	2,110	$29K	0.0%	N/A	0.004%
8/6/2024	Los Angeles Capital Management LLC	66,765	$0.90M	0.0%	+7.2%	0.128%
8/1/2024	Rhumbline Advisers	47,860	$0.65M	0.0%	+14.3%	0.092%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	9,129	$0.12M	0.0%	N/A	0.018%
7/26/2024	Bank of New York Mellon Corp	115,892	$1.57M	0.0%	+28.9%	0.222%
7/20/2024	Nisa Investment Advisors LLC	2,989	$40K	0.0%	+53.2%	0.006%
7/18/2024	Assenagon Asset Management S.A.	1,468,202	$19.84M	0.0%	N/A	2.817%
7/12/2024	SG Americas Securities LLC	68,601	$0.93M	0.0%	+610.3%	0.132%

Data available starting January 2016

See Full Table

Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary targeted augmentation of nuclear gene output to develop antisense oligonucleotides to selectively restore protein levels. Its lead clinical candidate is STK-002, which is in preclinical stage for the treatment of autosomal dominant optic atrophy. The company also develops STK-001, which is in phase I/II clinical trial to treat Dravet syndrome; and programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye. The company has a license and collaboration agreement with Acadia Pharmaceuticals Inc. for the discovery, development, and commercialization of novel RNA-based medicines for the treatment of severe and rare genetic neurodevelopmental diseases of the central nervous system. The company was formerly known as ASOthera Pharmaceuticals, Inc. and changed its name to Stoke Therapeutics, Inc. in May 2016. Stoke Therapeutics, Inc. was incorporated in 2014 and is headquartered in Bedford, Massachusetts.

Today's Range

Now: $7.21

$7.06

$7.48

50 Day Range

MA: $9.32

$7.21

$12.74

52 Week Range

Now: $7.21

$7.06

$17.58

Volume

572,399 shs

Average Volume

724,092 shs

Market Capitalization

$389.90 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.99

Who are the company insiders with the largest holdings of Stoke Therapeutics?: Stoke Therapeutics' top insider shareholders include:
Skorpios Trust (Major Shareholder)
Edward M Md Kaye (Director)
Barry Ticho (Insider)
Edward M Md Kaye (CEO)
Jonathan Allan (General Counsel)
Stephen J Tulipano (CFO)
Learn More about top insider investors at Stoke Therapeutics.
Who are the major institutional investors of Stoke Therapeutics?: Stoke Therapeutics' top institutional shareholders include:
Skorpios Trust — 13.04%
RTW Investments LP — 9.67%
Baker BROS. Advisors LP — 8.75%
Redmile Group LLC — 8.67%
Toronto Dominion Bank — 5.99%
Toronto Dominion Bank — 5.99%
Learn More about top institutional investors of Stoke Therapeutics stock.
Which institutional investors are selling Stoke Therapeutics stock?: During the last quarter, STOK stock was sold by these institutional investors:
Skorpios Trust
Marshall Wace LLP
Jane Street Group LLC
D. E. Shaw & Co. Inc.
Redmile Group LLC
Bank of America Corp DE
Deutsche Bank AG
Granahan Investment Management LLC
During the last year, company insiders that have sold Stoke Therapeutics company stock include:
Skorpios Trust (Major Shareholder)
Edward M Md Kaye (Director)
Barry Ticho (Insider)
Edward M Md Kaye (CEO)
Jonathan Allan (General Counsel)
Learn More investors selling Stoke Therapeutics stock.
Which institutional investors are buying Stoke Therapeutics stock?: In the last quarter, STOK stock was purchased by institutional investors including:
Toronto Dominion Bank
Toronto Dominion Bank
RTW Investments LP
Norges Bank
Tang Capital Management LLC
Schonfeld Strategic Advisors LLC
Dimensional Fund Advisors LP
Baker BROS. Advisors LP